Sunesis Pharmaceuticals, Inc. Soared
Thu, Feb 25, 2021 at 05:30 PM
Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ) rocketted at $5.32, representing a gain of 24.3%. On Wed 24 Feb 21, SNSS:NASDAQ hit a New 2-Week High of $5.32. The stock got featured on our News Catalysts scanner on Wed 24 Feb 21 at 04:49 PM in the 'MERGER' category. From Wed 10 Feb 21, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Wed 24 Feb 21 at $7.09 with a volume of 70M+.
About Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ)
Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
Top 10 Gainers:
- PAND (PAND:NASDAQ), 133.36%
- ChromaDex Corporation (CDXC:NASDAQ), 92.4%
- TDH Holdings, Inc. (PETZ:NASDAQ), 34.73%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 26.7%
- Dynatronics Corporation (DYNT:NASDAQ), 25%
- Workhorse Group Inc. (WKHS:NASDAQ), 24.72%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%
- GameStop Corp. (GME:NYSE), 18.56%
- Brookdale Senior Living Inc. (BKD:NYSE), 18.53%
- TIRX (TIRX:NASDAQ), 17.11%